Volume 21, Number 9—September 2015
THEME ISSUE
Emerging Infections Program
Emerging Infections Program
Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae
Table 2
Isolates used in a study evaluating phenotype-based definitions for reliability in identifying carbapenemase producers among carbapenem-resistant enterobacterial isolates from 6 US Emerging Infections Program sites, January 1, 2011–January 30, 2014
Site | No. (%) isolates |
Total no. isolates, N = 312 | ||
---|---|---|---|---|
Klebsiella spp., n = 111 | Enterobacter spp., n = 103 | Escherichia coli, n = 98 | ||
Minnesota | 30 (27) | 63 (56) | 19 (17) | 112 |
Tennessee | 17 (25) | 11 (16) | 41 (59) | 69 |
Maryland | 48 (81) | 0 | 11 (19) | 59 |
New York | 11 (20) | 20 (38) | 22 (42) | 53 |
New Mexico | 5 (33) | 6 (40) | 4 (27) | 15 |
Colorado | 0 | 3 (75) | 1 (25) | 4 |
Page created: August 12, 2015
Page updated: August 12, 2015
Page reviewed: August 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.